Expanded results from the first-of-its-kind clinical trial explores the use of SGLT2 inhibitor for COVID-19 patients with hypertension
Published: Sunday, June 27, 2021
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.